Abstract:Introduction: The application of microdissection testicular sperm extraction (micro-TESE) to retrieve the sperm of patients with non-obstructive azoospermia (NOA) has greatly increased. Patients with NOA often have poor quality sperm. Unfortunately, there are few studies on artificial oocyte activation (AOA) performed on patients who successfully retrieved motile and immotile sperm by micro-TESE after intracytoplasmic sperm injection (ICSI). Therefore, this study sought to obtain more comprehensive evidence-based data and embryo development outcomes to aid consultation of patients with NOA who opted to receive assisted reproductive techniques and to determine whether AOA needs to be performed in different motile sperm after ICSI. Methods: This retrospective study involved 235 patients with NOA who underwent micro-TESE to retrieve adequate sperm for ICSI between January 2018 and December 2020. A total of 331 ICSI cycles were performed in the 235 couples. Embryological, clinical, and neonatal outcomes were demonstrated comprehensively between motile sperm and immotile sperm using AOA and non-AOA treatment. Results: Motile sperm injection with AOA (group 1) showed significantly higher fertility rate (72.77% vs. 67.59%, p =0.005), 2 pronucleus (2PN) fertility rate (64.33% vs. 60.22%, p =0.036), and miscarriage rate (17.65% vs. 2.44%, p =0.018) compared with motile sperm injection with non-AOA (group 2). Group 1 had comparable available embryo rate (41.29% vs. 40.74%, p =0.817), good embryo rate (13.44% vs. 15.44%, p =0.265), and without an embryo for transfer rate (10.85% vs. 9.90%, p =0.815) compared with group 2. Immotile sperm injection with AOA (group 3) displayed significantly higher fertility rate (78.56% vs. 67.59%, p =0.000), 2PN fertility rate (67.36% vs. 60.22%, p =0.001), without an embryo for transfer rate (23.76% vs. 9.90%, p= 0.008), and miscarriage rate (20.00% vs. 2.44%, p =0.014), but significantly lower available embryo rate (26.63% vs. 40.74%, p =0.000) and good embryo rate (15.44% vs. 6.99%, p =0.000) compared with group 2. In groups 1, 2, and 3, the rates of implantation (34.87%, 31.85% and 28.00%, respectively; p =0.408), clinical pregnancy (43.87%, 41.00%, and 34.48%, respectively; p =0.360) and live birth (36.13%, 40.00%, and 27.59%, respectively; p =0.194) were similar. Discussion: For those patients with NOA from whom adequate sperm were retrieved for ICSI, AOA could improve fertilization rate, but not embryo quality and live birth outcomes. For patients with NOA and only immotile sperm, AOA can help achieve acceptable fertilization rate and live birth outcomes. AOA is recommended for patients with NOA only when immotile sperm are injected.

The study of microtraumatic sperm retrieval and intracytoplasmic sperm injection for the obstructive azoospermia

Comparison Between the Results of ICSI with Fresh and with Frozen-thawed Sperm Obtained by PESA to Treat Azoospermia

[Outcome of Intracytoplasmic Injection of Epididymal and Testicular Sperm Obtained from Azoospermic Patients].

[Sperm Retrieval Methods and Pregnancy Outcome of 100 Azoospermia Patients].

The analysis of clinical characteristics and the results of ICSI in 146 cases with post-inflamatory obstructive azoospermia

Comparative Clinical Study of Percutaneous Epididymal Sperm Aspiration and Testicular Biopsy in the Outcome of ICSI-Assisted Fertility Treatment in Patients with Obstructive Azoospermia

[Outcomes of Micro-Tese Combined with ICSI for Non-Obstructive Azoospermia].

The Efficacy of Microvasoepididymostomy for the Treatment of Obstructive Azoospermia

Clinical Outcome of Microsurgical Vasoepididymostomy Versus Epididymal or Testicular Sperm Retrieval Combined with Intracytoplasmic Sperm Injection in Obstructive Azoospermia Males.

Embryo development and live birth resulted from artificial oocyte activation after microdissection testicular sperm extraction with ICSI in patients with non-obstructive azoospermia

Comparison of the outcome of intracytoplasmic sperm injection in men with obstructive and non-obstructive azoospermia

Sperm Retrieval Rates And Clinical Outcomes For Patients With Different Causes Of Azoospermia Who Undergo Microdissection Testicular Sperm Extraction-Intracytoplasmic Sperm Injection

[Application of Percutaneous Epididymal Sperm Aspiration and Testicular Sperm Extraction to the Diagnosis and Treatment of Azoospermia].

Clinical Outcomes Of Microdissection Testicular Sperm Extraction-Intracytoplasmic Sperm Injection With Fresh Or Cryopreserved Sperm In Patients With Nonobstructive Azoospermia

Surgical Retrieval of Testicular Spermatozoa and Intracytoplasmic Sperm Injection in Non-Obstructive Azoospermic Patients

Resolving Male Infertility: A Case Report on Treating Obstructive Azoospermia Using SpermMobil in Intracytoplasmic Sperm Injection Procedure

Impact on Using Cryopreservation of Testicular or Epididymal Sperm Upon Intracytoplasmic Sperm Injection Outcome in Men with Obstructive Azoospermia: a Systematic Review and Meta-Analysis

Successful Sperm Retrieval and Clinical Pregnancies Following Micro-TESE and ICSI Treatments in Patients with Nonobstructive Azoospermia Due to Various Etiologies

Clinical application of ICSI with frozen-thawed testicular sperm for azoospermia patients.

Does ICSI outcome in obstructive azoospermia differ according to the origin of retrieved spermatozoa or the cause of epididymal obstruction? A comparative study

Primary Evaluation of Testicular Biopsy and Pathological Examination on Status of Sperm Detectable Rate from Patients with Obstructive Azoospermia